Apr 29, 2013
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.07 to $0.00.
The split itself did not change the total investment value.
Silence Therapeutics plc (SLNCF) trades on the Other OTC in the Biotechnology industry.
Silence Therapeutics plc company overviewThe latest split shown was on April 29, 2013. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records 3 splits between April 27, 2011 and April 29, 2013.
Already premium?